Our findings indicate that MTH1 expression was altered during ESCC carcinogenesis and progression and suggest that MTH1 could be used as a predictive biomarker of poor prognosis in patients with ESCC. Here, NUDT1 is linked to esophageal squamous cell carcinoma.